Jane Hankins
Director, St. Jude Global Hematology Program · St Jude Children's Research Hospital
Credentials: · · ·
History
Research
R2* magnetic resonance imaging of the liver in patients with iron overload
Blood · 2009 · First of 10 authors · Corresponding · 313 citations
Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study
Blood · 2005 · First of 7 authors · Corresponding · 227 citations
The Lancet Haematology · 2019 · 172 citations
54 papers
43 papers
40 papers
36 papers
- JE
24 papers
23 papers
22 papers
20 papers
Grants
- 2016–2023
RE-Aiming at Hydroxyurea Adherence for Sickle Cell with mHealth (RE-HASH)
National Heart, Lung, and Blood Institute · U01
Contact PI · $4.6M · St. Jude Children's Research Hospital
- 2010–2015
Sparing Conversion to Abnormal TCD Elevation
National Heart, Lung, and Blood Institute · R01
PI · $2M · Cincinnati Childrens Hosp Med Ctr
- 2010–2015
Massive Iron Deposit Assessment (MIDAS)
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $1.5M · St. Jude Children's Research Hospital
Clinical trials
- 2026–2031
Universal Newborn Screening For Sickle Cell Disease In Mozambique
Principal investigator · Not yet recruiting
St. Jude Children's Research Hospital
- 2019–2022
Principal investigator · Completed
St. Jude Children's Research Hospital
- 2017–2018
Re-Aiming at Hydroxyurea Adherence for Sickle Cell With mHealth
Principal investigator · Completed
St. Jude Children's Research Hospital
- 2014–2016
A New Reagent Assay Examining Natural Parvovirus B19 Infection in Sickle Cell Disease
Principal investigator · Completed
St. Jude Children's Research Hospital